drug-development
-
Raptor announces results of cysteamine trial for Huntington's disease
Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease
-
Huntington's Disease Therapeutics Conference 2014: day 1
HDBuzz reports from the opening day of science sessions at the 2014 HD Therapeutics Conference in Palm Springs.
-
Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
Results are in for a clinical trial testing the drug PBT2 for HD. Are the claims in the announcement justified?
-
Is a new Huntington’s Disease drug study on the right Trk?
A recent HD animal study reveals that a small molecule drug could be an effective “Trk” to target for HD therapeutics
-
New study sheds light on regional degeneration in HD
Why do certain brain cells die in HD? New research suggests is may be due to the efficiency of cellular recycling
-
What the 'big neurodegeneration breakthrough' means for Huntington's disease
Are recent findings in mice injected with 'prions' as important for Huntington's disease as widely reported?
By Eric Minikel